[Indications of automatic ventricular implantable defibrillator. Implications for daily practice]

Area of Science:

• Cardiology
• Electrophysiology
• Medical Device Technology

Background:

• Development of guidelines for automatic implantable cardioverter-defibrillators (ICD) by the French Society of Cardiology.
• Adaptation of existing US indications and incorporation of data from controlled studies.

Observation:

• Three Class I indications for ICDs were identified.
• Three Class II indications for ICDs were identified.

Findings:

• Class I indications include circulatory arrest from ventricular tachycardia (VT) or fibrillation (VF) without acute cause, sustained VT with heart disease, and non-sustained VT post-myocardial infarction with low ejection fraction.
• Class II indications involve inheritable diseases with high sudden death risk, syncope with inducible VT/VF, and VT/VF in heart transplant candidates.

Implications:

• Provides a framework for appropriate ICD implantation in diverse patient populations.
• Aims to improve outcomes and reduce sudden cardiac death through evidence-based recommendations.
• Highlights the evolving role of ICDs in managing complex cardiac arrhythmias.